Truqap: payments to doctors
Payments that named Truqap as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $666K
- Providers
- 300
- Transactions
- 516
- Average per transaction
- $1,290
The per-transaction average — $1,290 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 300 providers the average total is $2,219, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $535,166 | 80.4% |
| Astrazeneca UK Limited | $129,918 | 19.5% |
| Astrazeneca AB | $685 | 0.1% |